The Future of Analytical and Interpretative Toxicology: Where are We Going and How Do We Get There?

被引:6
作者
Wille, Sarah M. R. [1 ]
Elliott, Simon [2 ,3 ]
机构
[1] Natl Inst Criminalist & Criminol, Dept Toxicol, Brussels, Belgium
[2] Elliott Forens Consulting Ltd, Birmingham, W Midlands, England
[3] Kings Coll London, Dept Analyt Environm & Forens Sci, London, England
关键词
DEPENDENT POSTMORTEM REDISTRIBUTION; ALTERNATIVE MATRICES; DRUG-INTERACTIONS; PSYCHOACTIVE SUBSTANCES; ACUTE INTOXICATION; POTENTIAL MARKERS; OPIOID WITHDRAWAL; BAYESIAN NETWORK; BLOOD-SAMPLES; PHARMACOGENETICS;
D O I
10.1093/jat/bkaa133
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
(Forensic) toxicology has faced many challenges, both analytically and interpretatively, especially in relation to an increase in potential drugs of interest. Analytical toxicology and its application to medicine and forensic science have progressed rapidly within the past centuries. Technological innovations have enabled detection of more substances with increasing sensitivity in a variety of matrices. Our understanding of the effects (both intended and unintended) have also increased along with determination and degree of toxicity. However, it is clear there is even more to understand and consider. The analytical focus has been on typical matrices such as blood and urine but other matrices could further increase our understanding, especially in postmortem (PM) situations. Within this context, the role of PM changes and potential redistribution of drugs requires further research and identification of markers of its occurrence and extent. Whilst instrumentation has improved, in the future, nanotechnology may play a role in selective and sensitive analysis as well as bioassays. Toxicologists often only have an advisory impact on pre-analytical and pre-interpretative considerations. The collection of appropriate samples at the right time in an appropriate way as well as obtaining sufficient circumstance background is paramount in ensuring an effective analytical strategy to provide useful results that can be interpreted within context. Nevertheless, key interpretative considerations such as pharmacogenomics and drug-drug interactions as well as determination of tolerance remain and in the future, analytical confirmation of an individual's metabolic profile may support a personalized medicine and judicial approach. This should be supported by the compilation and appropriate application of drug data pursuant to the situation. Specifically, in PM circumstances, data pertaining to where a drug was not/may have been/was contributory will be beneficial with associated pathological considerations. This article describes the challenges faced within toxicology and discusses progress to a future where they are being addressed.
引用
收藏
页码:619 / 632
页数:14
相关论文
共 124 条
  • [1] Molecularly Imprinted Polymers in Electrochemical and Optical Sensors
    Ahmad, Omar S.
    Bedwell, Thomas S.
    Esen, Cem
    Garcia-Cruz, Alvaro
    Piletsky, Sergey A.
    [J]. TRENDS IN BIOTECHNOLOGY, 2019, 37 (03) : 294 - 309
  • [2] Role of orexin type-1 receptors in paragiganto-coerulear modulation of opioid withdrawal and tolerance: A site specific focus
    Ahmadi-Soleimani, S. Mohammad
    Azizi, Hossein
    Gompf, Heinrich S.
    Semnanian, Saeed
    [J]. NEUROPHARMACOLOGY, 2017, 126 : 25 - 37
  • [3] Development and validation of a Partial Least Squares-Discriminant Analysis (PLS-DA) model based on the determination of ethyl glucuronide (EtG) and fatty acid ethyl esters (FAEEs) in hair for the diagnosis of chronic alcohol abuse
    Alladio, E.
    Giacomelli, L.
    Biosa, G.
    Di Corcia, D.
    Gerace, E.
    Salomone, A.
    Vincenti, M.
    [J]. FORENSIC SCIENCE INTERNATIONAL, 2018, 282 : 221 - 230
  • [4] Evaluation of direct and indirect ethanol biomarkers using a likelihood ratio approach to identify chronic alcohol abusers for forensic purposes
    Alladio, Eugenio
    Martyna, Agnieszka
    Salomone, Alberto
    Pirro, Valentina
    Vincenti, Marco
    Zadora, Grzegorz
    [J]. FORENSIC SCIENCE INTERNATIONAL, 2017, 271 : 13 - 22
  • [5] [Anonymous], 2019, STOCKLEYS DRUG INTER
  • [6] [Anonymous], 2018, INT ASS FOR TOX M GH
  • [7] [Anonymous], 2016, FLOCKHART TALBLE IND
  • [8] [Anonymous], 2019, WORLD HLTH ORG ADVER
  • [9] Pharmacogenetic prediction of clozapine response
    Arranz, MJ
    Munro, J
    Birkett, J
    Bolonna, A
    Mancama, D
    Sodhi, M
    Lesch, KP
    Meyer, JFW
    Sham, P
    Collier, DA
    Murray, RM
    Kerwin, RW
    [J]. LANCET, 2000, 355 (9215) : 1615 - 1616
  • [10] Drug abuse screening with exhaled breath and oral fluid in adults with substance use disorder
    Arvidsson, Michel
    Ullah, Shahid
    Franck, Johan
    Dahl, Marja-Liisa
    Beck, Olof
    [J]. DRUG TESTING AND ANALYSIS, 2019, 11 (01) : 27 - 32